Real-world use of Safinamide in motor fluctuating Parkinson’s disease patients in Italy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Real-world use of Safinamide in motor fluctuating Parkinson’s disease patients in Italy ; day:9 ; month:9 ; year:2023 ; pages:1-11
Neurological sciences ; (9.9.2023), 1-11
- Urheber
-
Bovenzi, Roberta
Liguori, Claudio
Canesi, Margherita
D’Amelio, Marco
Pandis, Maria Francesca De
Marini, Carmine
Monge, Alessandra
Padovani, Alessandro
Tessitore, Alessandro
Stefani, Alessandro
Zappia, Mario
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10072-023-07001-6
- URN
-
urn:nbn:de:101:1-2023112215342337406627
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bovenzi, Roberta
- Liguori, Claudio
- Canesi, Margherita
- D’Amelio, Marco
- Pandis, Maria Francesca De
- Marini, Carmine
- Monge, Alessandra
- Padovani, Alessandro
- Tessitore, Alessandro
- Stefani, Alessandro
- Zappia, Mario
- SpringerLink (Online service)
Ähnliche Objekte (12)
Application of single wrist-wearable accelerometry for objective motor diary assessment in fluctuating Parkinson’s disease
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson’s disease patients: a prospective longitudinal study
Intercultural translation and application of the German version of King’s Parkinson’s disease pain questionnaire in fluctuating Parkinson’s disease
Real-World Evidence for a Smartwatch-Based Parkinson’s Motor Assessment App for Patients Undergoing Therapy Changes
Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson’s disease - network meta-analysis
Disease progression strikingly differs in research and real-world Parkinson’s populations
Gender differences in non-motor fluctuations in Parkinson’s disease
Home monitoring of motor fluctuations in Parkinson’s disease patients
Non-motor symptoms in newly diagnosed Parkinson’s disease patients
Impact of advanced Parkinson’s disease on caregivers: an international real-world study
Application of single wrist-wearable accelerometry for objective motor diary assessment in fluctuating Parkinson’s disease
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson’s disease patients: a prospective longitudinal study
Intercultural translation and application of the German version of King’s Parkinson’s disease pain questionnaire in fluctuating Parkinson’s disease
Real-World Evidence for a Smartwatch-Based Parkinson’s Motor Assessment App for Patients Undergoing Therapy Changes
Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson’s disease - network meta-analysis
Disease progression strikingly differs in research and real-world Parkinson’s populations
Gender differences in non-motor fluctuations in Parkinson’s disease
Home monitoring of motor fluctuations in Parkinson’s disease patients
Non-motor symptoms in newly diagnosed Parkinson’s disease patients
Impact of advanced Parkinson’s disease on caregivers: an international real-world study
Application of single wrist-wearable accelerometry for objective motor diary assessment in fluctuating Parkinson’s disease
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson’s disease patients: a prospective longitudinal study
Intercultural translation and application of the German version of King’s Parkinson’s disease pain questionnaire in fluctuating Parkinson’s disease
Real-World Evidence for a Smartwatch-Based Parkinson’s Motor Assessment App for Patients Undergoing Therapy Changes
Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson’s disease - network meta-analysis
Disease progression strikingly differs in research and real-world Parkinson’s populations
Gender differences in non-motor fluctuations in Parkinson’s disease
Home monitoring of motor fluctuations in Parkinson’s disease patients
Non-motor symptoms in newly diagnosed Parkinson’s disease patients